General MedicationsORALGeneric
CLONIDINE
CLONIDINE
Standard Dose
EQ 0.09MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary
Approval overview CLONIDINE is listed in Drugs@FDA under application 022499 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CLONIDINE Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 0.09MG BASE/ML Sponsor TRIS PHARMA INC Submission history Latest submission status date: 2010-09-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLONIDINE is listed in Drugs@FDA under application 022499 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient CLONIDINE Form and strength SUSPENSION, EXTENDED RELEASE;ORAL - EQ 0.09MG BASE/ML Sponsor TRIS PHARMA INC Submission history Latest submission status date: 2010-09-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.